Becton Dickinson & Co (NYSE:BDX)
$ 235.67 0.67 (0.29%) Market Cap: 68.11 Bil Enterprise Value: 82.95 Bil PE Ratio: 51.91 PB Ratio: 2.65 GF Score: 82/100

Becton Dickinson and Co at Wells Fargo Virtual Healthcare Conference Transcript

Sep 10, 2020 / 12:40PM GMT
Release Date Price: $228.31 (-0.59%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

We have Becton, Dickinson with us for this session. Joining us from the company are the President and CEO, Tom Polen; the CFO, Chris Reidy; and Kristen Stewart, the new Senior Vice President of Strategy and Investor Relations. I'm flattered that Kristen has made our conference, her first one.

So in terms of format, this will be a 30-minute fireside chat. Tom, Chris and Kristen, welcome, and thanks for joining us.

Thomas E. Polen
Becton, Dickinson and Company - President, CEO & Director

Good morning, Larry.

Christopher R. Reidy
Becton, Dickinson and Company - Executive VP, CFO & Chief Administrative Officer

Good morning, Larry.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Great. So Tom, let's start at a high level. Investors are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot